You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Cubist agrees to acquire 2 drug makers

Lexington-based Cubist makes Cubicin.

istockphoto.com

Lexington-based Cubist makes Cubicin.

Continue reading below

Cubist Pharmaceuticals Inc., best-known for its antibiotic Cubicin, will pay up to $1.6 billion to acquire two other drug makers in a bid to increase its line of antibiotics. The deal to buy Optimer Pharmaceuticals and Trius Therapeutics adds an antibacterial drug to its product portfolio and puts several other antibiotics in its pipeline for approval. The deals are expected to ultimately generate between $600 million and $1 billion in annual revenue, Cubist CEO Michael Bonney said.

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.